Clinical Trial Update: Efficacy and Safety of Tazbentetol in ALS Participants [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of Tazbentetol for amyotrophic lateral sclerosis, with enrollment not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tazbentetol

Snippet

Sponsor: Spinogenix | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING